Alzheimer's disease (AD) is the most common type of dementia and is estimated to affect 5 million individuals in the United States. Of all individuals over age 65 years, an estimated 6-8% have AD or another form of dementia and this rate exceeds 30% at age 85 years and older. Because the decline in cognitive abilities can be severe enough to interfere with daily life, clinicians who care for residents with AD can play a pivotal role in the diagnosis, treatment, and follow-up of these residents. As such, there is a significant need to provide long-term care clinicians with guidance on how to identify residents with AD, assess underlying mechanisms and disease severity, and how to establish and monitor an effective treatment plan.

To address these challenges, a quality improvement CME/CE activity was developed to help clinicians in long-term care facilities improve the outcomes for Alzheimer’s treatment. This toolkit was developed based on the QI activity and provides clinicians with additional tools, resources, and strategies to implement their own quality improvement activity.

VIEW A WEBCAST recorded as part of this initiative: http://accesscme.org/alzheimersLTC

This webcast provides additional information about Alzheimer’s Treatment in LTC, and is certified for CME/CE credit.

This QI CME/CE activity was co-sponsored by the Academy for Continued Healthcare Learning and Indiana University School of Medicine, and supported by an educational grant from Pfizer Inc.